1. Prohibition on contracting with certain biotechnology providers (a) In general The head of an Executive agency may not— (1) procure or obtain or extend or renew a contract to procure or obtain any covered biotechnology equipment or service; or (2) enter into a contract or extend or renew a contract with any entity that— (A) uses covered biotechnology equipment or services acquired after the date of the enactment of this Act; or (B) that enters into any contract the performance of which such entity knows or has reason to believe will require the direct use of covered biotechnology equipment or services. (b) Prohibition on loan and grant funds The head of an Executive agency may not obligate or expend loan or grant funds to— (1) procure or obtain or extend or renew a contract to procure or obtain any covered biotechnology equipment or service; or (2) enter into a contract or extend or renew a contract with an entity described in subsection (a)(2). (c) Effective date The prohibitions under subsections (a) and (b) shall take effect 180 days after the date of the enactment of this Act. (d) Waiver authorities (1) Specific biotechnology exception (A) Waiver The head of an Executive agency may waive the prohibitions under subsection (a) and (b) on a case-by-case basis— (i) with the approval of the Director of the Office of Management and Budget, in consultation with the Federal Acquisition Security Council and the Secretary of Defense